Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

WVE

Wave Life Sciences Ltd

Nov 27 • 04:00PM ET

14.99

Dollar change +0.16
Percentage change 1.08	%

Healthcare • Biotechnology • Singapore • NASD

Peers: IONS ALNY SRPT ARWR MRNA NBIX VRTX BIIB QURE EDIT

| Held by: IWM VXF IBB IWO SCHA VTWO KOMP VHT LFSC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.11	Insider Own	22.54%	Shs Outstand	119.16M	Perf Week	5.12%
Market Cap	2.29B	Forward P/E	-	EPS next Y	-1.06	Insider Trans	7.14%	Shs Float	118.14M	Perf Month	1.28%
Income	-142.52M	PEG	-	EPS next Q	-0.19	Inst Own	73.91%	Short Float	5.46%	Perf Quarter	162.52%
Sales	53.61M	P/S	42.65	EPS this Y	-113.04%	Inst Trans	44.70%	Short Ratio	3.54	Perf Half Y	142.95%
Book/sh	0.95	P/B	15.70	EPS next Y	8.22%	ROA	-51.04%	Short Interest	6.45M	Perf Year	192.77%
Cash/sh	2.04	P/C	7.35	EPS next 5Y	-	ROE	-243.82%	52W Range	3.50 - 16.74	Perf YTD	196.83%
Dividend Est.	-	P/FCF	-	EPS past 5Y	36.03%	ROI	-84.19%	52W High	-10.43%	Beta	-1.22
Dividend TTM	-	Quick Ratio	1.90	Sales past 5Y	610.91%	Gross Margin	83.79%	52W Low	328.29%	ATR (14)	0.97
Dividend Ex-Date	-	Current Ratio	1.90	EPS Y/Y TTM	-28.22%	Oper. Margin	-283.63%	RSI (14)	58.70	Volatility	5.28% 6.96%
Employees	268	Debt/Eq	0.18	Sales Y/Y TTM	-37.29%	Profit Margin	-265.84%	Recom	1.20	Target Price	22.60
Option/Short	Yes / Yes	LT Debt/Eq	0.13	EPS Q/Q	-812.54%	Payout	-	Rel Volume	0.33	Prev Close	14.83
Sales Surprise	-146.22%	EPS Surprise	-66.20%	Sales Q/Q	-115.60%	Earnings	Nov 12 BMO	Avg Volume	1.82M	Price	14.99
SMA20	2.68%	SMA50	23.66%	SMA200	105.59%	Trades		Volume	607,803	Change	1.08%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$22
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform	$13
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10
Nov-01-19	Initiated	Guggenheim	Buy	$43
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy	$49 → $33
Aug-07-18	Initiated	Stifel	Buy	$56
Jul-23-18	Initiated	H.C. Wainwright	Buy	$49
Mar-19-18	Reiterated	Mizuho	Buy	$34 → $65
Feb-15-17	Initiated	H.C. Wainwright	Buy	$41
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy	$26

Show Previous Ratings

Nov-26-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-15-24 08:30AM	Wave Life Sciences to Present at Jefferies London Healthcare Conference (GlobeNewswire) -8.87%
Nov-13-24 02:08AM	WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Nov-12-24 09:00AM	Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Loading…
07:30AM	Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-11-24 07:08AM	WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 10:00AM	Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Nov-04-24 04:05PM	Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 (GlobeNewswire)
Oct-30-24 04:45PM	Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs (GlobeNewswire)
Oct-29-24 05:47PM	How to play biotech stocks: Insmed and Wave Life Sciences (Yahoo Finance Video)
Oct-28-24 09:55AM	Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know (Zacks)
Oct-24-24 05:53AM	1 Brand-New Big Reason to Buy This Biotech Stock Right Now (Motley Fool)
Oct-23-24 12:00PM	What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? (Zacks)
Oct-21-24 04:15PM	Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. (Investor's Business Daily)
10:56AM	Loading…
Oct-17-24 10:56AM	Wave Life Sciences Shares Surge After RNA Editing Discovery (GuruFocus.com)
07:33AM	Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? (Zacks)
Oct-16-24 04:20PM	Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed. (Investor's Business Daily) +74.07%
04:13PM	RNA-Editing Stocks Soar by Record on Wave Lifes Trial Data (Bloomberg)
01:16PM	Wave Life Sciences Stock Climbs on RNA Editing Progress (The Wall Street Journal)
08:44AM	Wave Life Sciences (WVE): Advancing Gene Therapy for Duchenne Muscular Dystrophy (Insider Monkey)
08:30AM	Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
08:25AM	Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024 (GlobeNewswire)
08:15AM	Wave sees RNA editing validation in early trial results (BioPharma Dive)
Oct-11-24 11:56AM	GSK Bought More Shares of Biotech Wave Life Sciences (Barrons.com)
09:55AM	How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71% (Zacks)
Oct-09-24 05:36PM	WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com) +5.12%
Oct-03-24 08:15AM	Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics (Motley Fool)
Oct-01-24 09:20AM	Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Sep-30-24 08:30AM	Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference (GlobeNewswire)
09:14PM	Loading…
Sep-25-24 09:14PM	Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +10.01% -10.99%
06:32AM	Waves stock swells as it eyes approval following Phase II DMD victory (Clinical Trials Arena)
Sep-24-24 04:01PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +53.37%
11:19AM	Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug (Benzinga)
07:30AM	Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping (GlobeNewswire)
Aug-24-24 01:17AM	Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE) (GuruFocus.com)
Aug-12-24 08:30AM	Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy (GlobeNewswire)
Aug-08-24 08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:47AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-24 08:30AM	Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024 (GlobeNewswire) -6.81%
Jun-25-24 07:30AM	Wave, with new data, plots path forward for Huntingtons drug (BioPharma Dive) -8.45%
07:30AM	Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington's Disease (GlobeNewswire)
Jun-12-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing (GlobeNewswire)
May-30-24 08:30AM	Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 07:16AM	Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target (MT Newswires)
May-10-24 04:53PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:39PM	WAVE Life Sciences Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:45AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
07:00AM	Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer (GlobeNewswire)
May-07-24 08:30AM	Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-02-24 08:30AM	Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024 (GlobeNewswire)
Apr-30-24 08:30AM	Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) (GlobeNewswire)
Apr-23-24 08:30AM	Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing (GlobeNewswire)
Mar-27-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire) +6.71%
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 10:47AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript (Insider Monkey) +8.43%
Mar-06-24 12:51PM	WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +31.32%
07:51AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-24 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 (GlobeNewswire)
04:16AM	Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains? (Zacks)
Feb-27-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire) +10.87%
Feb-06-24 01:17PM	Hedge Fund and Insider Trading News: John Paulson, Dan Loeb, Millennium Management, Wave Life Sciences Ltd. (WVE), Super Micro Computer Inc (SMCI), and More (Insider Monkey)
Jan-31-24 01:21PM	Hedge Fund and Insider Trading News: Ken Griffin, Seth Klarman, Millennium Management, Wave Life Sciences Ltd. (WVE), Columbia Banking System Inc (COLB), and More (Insider Monkey)
Jan-08-24 08:00AM	Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones (GlobeNewswire) +5.06%
Jan-03-24 08:30AM	Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-23 08:30AM	Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire)
Dec-07-23 07:00AM	Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares (GlobeNewswire) -30.42%
Dec-06-23 04:10PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +9.22%
04:08PM	Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Nov-22-23 08:30AM	Wave Life Sciences to Present at 6 Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-11-23 12:09PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:38AM	WAVE Life Sciences Ltd (WVE) Reports Notable Shift to Profitability in Q3 2023 (GuruFocus.com) -9.55%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 04:05PM	Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023 (GlobeNewswire) +6.02%
Sep-29-23 05:47AM	Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-28-23 04:15PM	Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day (GlobeNewswire) +8.71%
Sep-25-23 08:30AM	Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-06-23 08:30AM	Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 07:30AM	Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual R&D Day (GlobeNewswire)
Aug-23-23 11:13AM	WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months (GuruFocus.com) +6.99%
Aug-17-23 08:44AM	11 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
06:40AM	7 A-Rated Biotech Stocks for Your August Buy List (InvestorPlace)
Aug-10-23 12:40PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 06:02AM	Analyst Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher (Simply Wall St.)
Aug-04-23 06:45AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) 42% Price Boost Is Out Of Tune With Revenues (Simply Wall St.)
Aug-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +15.79%
07:53AM	Wave Life Sciences: Q2 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-27-23 08:30AM	Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023 (GlobeNewswire)
Jul-06-23 08:40AM	Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago (Simply Wall St.)
Jun-26-23 08:30AM	Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
Jun-19-23 08:00AM	Top Penny Stocks for Q3 2023 (Investopedia)
May-23-23 07:30AM	Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (GlobeNewswire)
May-16-23 08:30AM	Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting (GlobeNewswire) -7.94%
May-08-23 06:03AM	The Consensus EPS Estimates For Wave Life Sciences Ltd. (NASDAQ:WVE) Just Fell Dramatically (Simply Wall St.)
May-05-23 06:19AM	Wave Life Sciences First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) +9.32%

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOLNO PAUL	President and CEO	Nov 25 '24	Option Exercise	2.48	50,000	124,000	267,351	Nov 27 09:00 PM
BOLNO PAUL	President and CEO	Nov 25 '24	Sale	15.00	50,000	750,000	217,351	Nov 27 09:00 PM
PAUL BOLNO	Officer	Nov 25 '24	Proposed Sale	15.00	50,000	750,000		Nov 25 05:09 PM
BOLNO PAUL	President and CEO	Nov 15 '24	Sale	14.32	51,234	733,671	217,351	Nov 15 09:00 PM
PAUL BOLNO	Officer	Nov 15 '24	Proposed Sale	14.32	51,234	733,743		Nov 15 04:16 PM
Francis Chris	See Remarks	Nov 08 '24	Option Exercise	8.17	36,000	294,120	36,000	Nov 13 08:00 PM
Francis Chris	See Remarks	Nov 08 '24	Sale	16.00	36,000	576,000	0	Nov 13 08:00 PM
CHRISTOPHER FRANCIS	Officer	Nov 08 '24	Proposed Sale	16.00	36,000	576,000		Nov 08 04:14 PM
Francis Chris	See Remarks	Oct 16 '24	Option Exercise	2.88	129,122	371,410	65,625	Oct 18 08:00 PM
Francis Chris	See Remarks	Oct 16 '24	Sale	13.67	208,836	2,855,051	0	Oct 18 08:00 PM
BOLNO PAUL	President and CEO	Oct 16 '24	Sale	15.00	90,474	1,357,110	268,585	Oct 18 08:00 PM
CHRISTOPHER FRANCIS	Officer	Oct 16 '24	Proposed Sale	13.67	208,836	2,855,051		Oct 16 04:19 PM
PAUL BOLNO	Officer	Oct 16 '24	Proposed Sale	15.00	90,474	1,357,110		Oct 16 04:13 PM
Moran Kyle	Chief Financial Officer	Oct 11 '24	Option Exercise	2.48	25,000	62,000	44,777	Oct 11 08:00 PM
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM
Moran Kyle	Chief Financial Officer	Sep 25 '24	Sale	9.00	17,146	154,314	19,777	Sep 27 08:00 PM
KYLE MORAN	Officer	Sep 25 '24	Proposed Sale	9.00	17,146	154,314		Sep 25 09:40 PM
BOLNO PAUL	President and CEO	Aug 21 '24	Sale	5.78	48,366	279,555	359,059	Aug 23 06:00 PM
PAUL BOLNO	Officer	Aug 21 '24	Proposed Sale	5.78	48,366	279,638		Aug 21 04:24 PM
Vargeese Chandra	See Remarks	Jul 22 '24	Option Exercise	2.48	68,210	169,161	185,061	Jul 24 05:54 PM
Moran Kyle	Chief Financial Officer	Apr 03 '24	Sale	6.17	15,630	96,421	33,921	Apr 05 08:00 PM
GSK plc	10% Owner	Dec 07 '23	Buy	5.00	3,300,000	16,500,000	13,983,761	Jan 30 04:39 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Dec 11 '23	Buy	5.00	1,000,000	5,000,000	19,202,009	Dec 13 04:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WVE

Wave Life Sciences Ltd

Upgrade your FINVIZ experience